down arrow

Panacea Biotec

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE922B01023
  • NSEID: PANACEABIO
  • BSEID: 531349
INR
452.90
16.95 (3.89%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.09 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

434.30458.00

52 Week

112.70489.00
Valuation
Technical
Day's Volume

CASH

1.09 lacs (-64.60%) Volume

Shareholding (Dec 2024)

FII

0.38%

Held by 6 FIIs

DII

1.17%

Held by 0 DIIs

Promoter

72.49%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0%

  • Poor long term growth as Net Sales has grown by an annual rate of 0.79% and Operating profit at 10.99% over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -6.17
2

Risky - Negative EBITDA

3

Despite the size of the company, domestic mutual funds hold only 0% of the company

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 2,774 Cr (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.19

stock-summary
Return on Equity

-3.17%

stock-summary
Price to Book

3.21

Revenue and Profits (1 Year):
Net Sales:
163 Cr
(Quarterly Results - Dec 2024)
Net Profit:
5 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
46.1%
0%
46.1%
1 Year
210.21%
0%
210.21%
2 Years
277.42%
0%
277.42%
3 Years
145.27%
0%
145.27%
4 Years
94.0%
0%
94.0%
5 Years
246.78%
0%
246.78%

Latest dividend: 0.75 per share ex-dividend date: Sep-19-2011

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0.79%
EBIT Growth (5y)
10.99%
EBIT to Interest (avg)
-6.17
Debt to EBITDA (avg)
7.28
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.81
Tax Ratio
13.06%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
1.55%
ROCE (avg)
-8.56%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
33
Price to Book Value
3.21
EV to EBIT
-62.44
EV to EBITDA
-495.93
EV to Capital Employed
3.71
EV to Sales
4.47
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-7.17%
ROE (Latest)
-3.17%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 6 FIIs (0.38%)

Promoter with highest holding

Dr. Rajesh Jain (49.33%)

Highest Public shareholder

Magic Square Hospitality Services Llp (2.18%)

Individual Investors Holdings

18.98%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 8.63% vs 30.64% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 298.25% vs -111.77% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "163.49",
          "val2": "150.50",
          "chgp": "8.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7.96",
          "val2": "-0.15",
          "chgp": "5,406.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.99",
          "val2": "0.85",
          "chgp": "16.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "2.77",
          "val2": "2.78",
          "chgp": "-0.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4.52",
          "val2": "-2.28",
          "chgp": "298.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "4.87%",
          "val2": "-0.10%",
          "chgp": "4.97%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -3.36% vs 26.13% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -515.24% vs 106.65% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "263.07",
          "val2": "272.21",
          "chgp": "-3.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-6.99",
          "val2": "-13.87",
          "chgp": "49.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.85",
          "val2": "1.91",
          "chgp": "-3.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "5.51",
          "val2": "30.51",
          "chgp": "-81.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-11.17",
          "val2": "2.69",
          "chgp": "-515.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2.66%",
          "val2": "-5.10%",
          "chgp": "2.44%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 0.91% vs 27.70% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -1,721.95% vs 101.95% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "426.56",
          "val2": "422.71",
          "chgp": "0.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.97",
          "val2": "-14.02",
          "chgp": "106.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.84",
          "val2": "2.76",
          "chgp": "2.90%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "8.28",
          "val2": "33.29",
          "chgp": "-75.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-6.65",
          "val2": "0.41",
          "chgp": "-1,721.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.23%",
          "val2": "-3.32%",
          "chgp": "3.55%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 21.57% vs -30.44% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 96.53% vs -103.13% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "559.17",
          "val2": "459.95",
          "chgp": "21.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-20.06",
          "val2": "-97.96",
          "chgp": "79.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.58",
          "val2": "4.44",
          "chgp": "-19.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "36.03",
          "val2": "102.66",
          "chgp": "-64.90%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.17",
          "val2": "-33.75",
          "chgp": "96.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-3.59%",
          "val2": "-21.30%",
          "chgp": "17.71%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
163.49
150.50
8.63%
Operating Profit (PBDIT) excl Other Income
7.96
-0.15
5,406.67%
Interest
0.99
0.85
16.47%
Exceptional Items
2.77
2.78
-0.36%
Consolidate Net Profit
4.52
-2.28
298.25%
Operating Profit Margin (Excl OI)
4.87%
-0.10%
4.97%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 8.63% vs 30.64% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is 298.25% vs -111.77% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
263.07
272.21
-3.36%
Operating Profit (PBDIT) excl Other Income
-6.99
-13.87
49.60%
Interest
1.85
1.91
-3.14%
Exceptional Items
5.51
30.51
-81.94%
Consolidate Net Profit
-11.17
2.69
-515.24%
Operating Profit Margin (Excl OI)
-2.66%
-5.10%
2.44%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -3.36% vs 26.13% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is -515.24% vs 106.65% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
426.56
422.71
0.91%
Operating Profit (PBDIT) excl Other Income
0.97
-14.02
106.92%
Interest
2.84
2.76
2.90%
Exceptional Items
8.28
33.29
-75.13%
Consolidate Net Profit
-6.65
0.41
-1,721.95%
Operating Profit Margin (Excl OI)
0.23%
-3.32%
3.55%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 0.91% vs 27.70% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is -1,721.95% vs 101.95% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
559.17
459.95
21.57%
Operating Profit (PBDIT) excl Other Income
-20.06
-97.96
79.52%
Interest
3.58
4.44
-19.37%
Exceptional Items
36.03
102.66
-64.90%
Consolidate Net Profit
-1.17
-33.75
96.53%
Operating Profit Margin (Excl OI)
-3.59%
-21.30%
17.71%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 21.57% vs -30.44% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 96.53% vs -103.13% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Panacea Biotec Ltd stock-summary
stock-summary
Panacea Biotec Ltd
Small Cap
Pharmaceuticals & Drugs
India's leading research-based health management company with established research, manufacturing and marketing capabilities are collectively known as Panacea Biotec Limited (PBL), which was incorporated on February 2, 1984 under the name of Panacea Drug (P) Ltd.
Company Coordinates stock-summary
Company Details
Ambala-Chandigarh Highway , Lalru Punjab : 140501
stock-summary
Tel: 91-1762-505900
stock-summary
http://www.panaceabiotec.com
stock-summary
companysec@panaceabiotec.com
Registrar Details
Skyline Financial Services Pvt Ltd , D-153/A, 1st Floor, Okhla Industrial Area, Phase - I, New Delhi
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."